Skip to content

Safety and Performance Evaluation of the AutoLap System

Safety and Performance Evaluation of the AutoLap System - a Feasibility Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01828580
Enrollment
36
Registered
2013-04-10
Start date
2012-12-31
Completion date
2014-06-30
Last updated
2014-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Scheduled for Hernia Repair, Cholecystectomy, Right Colectomy, Nissen Fundoplication and Sigmoid Resection

Keywords

laparoscopic Cholecystectomy, Gallbladder removal, laparoscope holder

Brief summary

The main objectives of this study are to evaluate the safety and performance of the AutoLap system in Laparoscopic Cholecystectomy procedures.

Interventions

DEVICEactive laparoscope positioner (AutoLap)

Sponsors

M.S.T. Medical Surgery Technology LTD.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

1. Signed and dated Informed Consent Form. 2. Patients between 18 and 75 years of age inclusive who were scheduled for elective laparoscopic Cholecystectomy procedure.

Exclusion criteria

1. Previous upper abdominal surgery and contraindications to Pneumoperitoneum. 2. Pregnancy. 3. Obesity (BMI \>35 Kg/m2). 4. Generalized peritonitis. 5. Septic shock from cholangitis. 6. Severe acute pancreatitis. 7. Uncorrected coagulopathy. 8. Previous abdominal operations which prevent safe abdominal access or progression of the procedure. 9. Advanced cirrhosis with failure of hepatic function. 10. Suspected gallbladder cancer. 11. Acute cholecystitis 12. Presence of any medical or psychiatric condition or any other condition that, in the opinion of the Investigator, could affect the successful participation of the patient in the study. 13. Patient participates in any other clinical study 60 days prior to the start of the study and throughout the study duration.

Design outcomes

Primary

MeasureTime frameDescription
Adverse eventsparticipants will be followed for the duration of hospital stay, an expected average of 1-2 daysNo conversion to open surgery from laparoscopic surgery due to using the AutoLap system 2) No AutoLap system related operative complications, that require further clinical intervention
Performance evaluationduring surgery -defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).The ability of the AutoLap system to successfully move the laparoscope to the surgeon's desired position

Secondary

MeasureTime frameDescription
system set-up timeduring surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).defined as the time required from connecting the AutoLap's ARM to the bed rail
Average total procedure timeduring surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).defined as the time from first abdominal incision until the surgical procedure is completed
Number of times that the laparoscope was removed for cleaningDuring surgery - defined as the time from the first abdominal incision until the surgical procedure is completed (skin incisions are closed).
Usability evaluationDuring surgery (at the end of the procedure)the AutoLap system usability in laparoscopic procedures will be assessed by a questionnaire. The questionnaire assesses the surgeon's satisfaction with the use of the AutoLap in regard to easiness of use, convenient of movement control and its ability to be used in the OR without interfering with the surgical flow

Countries

Israel, Italy, Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026